Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Net Income towards Common Stockholders for 16 consecutive years, with $57000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders rose 101.8% year-over-year to $57000.0 in Q4 2025; TTM through Dec 2025 was $5.0 million, a 130.23% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 130.23% from the prior year.
• Net Income towards Common Stockholders was $57000.0 for Q4 2025 at Xtant Medical Holdings, down from $1.3 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $9.2 million in Q3 2023 and troughed at -$5.0 million in Q3 2024.
• A 5-year average of -$1.1 million and a median of -$1.8 million in 2021 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders plunged 7531.03% in 2022 and surged 492.31% in 2023, its largest moves.
• Over 5 years, Net Income towards Common Stockholders stood at -$1.3 million in 2021, then jumped by 70.51% to -$373000.0 in 2022, then slumped by 1053.62% to -$4.3 million in 2023, then rose by 26.45% to -$3.2 million in 2024, then soared by 101.8% to $57000.0 in 2025.
• The last three Net Income towards Common Stockholders figures came in at $57000.0 (Q4 2025), $1.3 million (Q3 2025), and $3.6 million (Q2 2025), per Business Quant data.